Showing results (331-340 of 358) with videos related to

Sort By:
Pageof 36
Cell|February 16, 2021
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisNathan D Mathewson, Orr Ashenberg, Itay Tirosh, et al.
Science (New York, N.Y.)|April 21, 2018
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seqMariella G Filbin, Itay Tirosh, Volker Hovestadt, et al.
Nature Genetics|March 24, 2020
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinomaDavid J H Shih, Naema Nayyar, Ivanna Bihun, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2024
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burdenJohannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Acta Neuropathologica|May 25, 2026
Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degenerationTimothy E Richardson, Jonathan Cherry, Shrishtee Kandoi, et al.
The Journal of Infectious Diseases|March 8, 2023
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron VariantsDerek E Dimcheff, Christopher N Blair, Yuwei Zhu, et al.
Nature Communications|February 5, 2020
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological studyEric M Reiman, Joseph F Arboleda-Velasquez, Yakeel T Quiroz, et al.
The Lancet. Neurology|July 16, 2022
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy studyAndreas Charidimou, Gregoire Boulouis, Matthew P Frosch, et al.
Acta Neuropathologica|June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer diseaseCharles D Chen, Erin E Franklin, Yan Li, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
Pageof 36